Quick Answer
Immunocore Holdings plc reported Net Income of -$35.51 million for fiscal year 2025.
Immunocore Holdings plc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$35.51M | +30.5% |
| 2024 | -$51.09M | +7.6% |
| 2023 | -$55.29M | -5.2% |
| 2022 | -$52.54M | +70.8% |
| 2021 | -$180.03M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$177.0K | -102.0% | +98.3% |
| June 30, 2025 | -$10.30M | +11.3% | -305.1% |
| March 31, 2025 | $5.02M | +120.6% | -42.5% |
| September 30, 2024 | $8.74M | +864.2% | +175.2% |
| June 30, 2024 | -$11.62M | +31.7% | +52.5% |
| March 31, 2024 | -$24.44M | -25.6% | -2797.1% |
| September 30, 2023 | $906.0K | — | +105.3% |
| June 30, 2023 | -$17.01M | — | +12.5% |
- Immunocore Holdings plc showed an increase of +30.5% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Immunocore Holdings plc’s net income has grown by 80.3% (from -$180.03 million to -$35.51 million).
- The most recent figure is from Immunocore Holdings plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: